Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Perioperative betablockade].

K Skarvan1

  • 1Departement Anästhesie, Universitätsspital Basel, Svýcarsko. skarvan@bluewin.ch

Casopis Lekaru Ceskych
|May 12, 2007
PubMed
Summary
This summary is machine-generated.

Prophylactic beta-blockade before non-cardiac surgery may not reduce cardiac events, despite guidelines. Physicians should weigh patient risk, surgery type, and potential side effects before prescribing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intra-operative assessment of pulmonary artery pressure by transoesophageal echocardiography.

Anaesthesia·2014
Same author

Volatile anaesthetics and positive pressure ventilation reduce left atrial performance: a transthoracic echocardiographic study in young healthy adults.

British journal of anaesthesia·2014
Same author

Remifentanil does not impair left ventricular systolic and diastolic function in young healthy patients.

British journal of anaesthesia·2011
Same author

Different effects of sevoflurane, desflurane, and isoflurane on early and late left ventricular diastolic function in young healthy adults.

British journal of anaesthesia·2010
Same author

[Volatile anesthetics and left ventricular diastolic function].

Der Anaesthesist·2009
Same author

Intra-operative myocardial ischaemia cannot be detected by analysis of transmitral inflow patterns in patients undergoing off-pump coronary surgery.

European journal of anaesthesiology·2007
Same journal

The personality of professor Otakar Štark in the context of the development of medical genetics in Czechoslovakia in the years 1950-1990.

Casopis lekaru ceskych·2026
Same journal

Václav Náprstek, MD - a forgotten hero.

Casopis lekaru ceskych·2026
Same journal

Professor Otto Piffl, the First Full Professor of Otology and Rhinology at the German University in Prague, passed away 100 years ago.

Casopis lekaru ceskych·2026
Same journal

Ancient sanctuary of Eileithyia, goddess of childbirth, on the island of Paros (Greece).

Casopis lekaru ceskych·2026
Same journal

European Partnership for Personalised Medicine (EP PerMed).

Casopis lekaru ceskych·2026
Same journal

Periodontitis and type 2 diabetes.

Casopis lekaru ceskych·2026
See all related articles

Area of Science:

  • Cardiology
  • Anesthesiology
  • Pharmacology

Context:

  • Adverse cardiac outcomes are a significant concern in non-cardiac surgery, particularly in aging populations with coronary artery disease.
  • Beta-blockers are established treatments for perioperative myocardial ischemia and arrhythmia.

Purpose:

  • To evaluate the efficacy and safety of prophylactic perioperative beta-blockade in patients undergoing major non-cardiac surgery.
  • To address the controversy surrounding the benefits of beta-blockade in this patient population.

Summary:

  • While guidelines recommend beta-blockers for at-risk patients undergoing non-cardiac surgery, recent studies and meta-analyses challenge their postulated benefits.
  • The effectiveness of prophylactic perioperative beta-blockade in reducing morbidity and mortality remains debated.

Related Experiment Videos

  • Ongoing large trials are expected to provide further clarity within two years.

    • Impact:

    • The decision to initiate prophylactic beta-blockade should be individualized, considering patient-specific risk factors, surgical procedure, and potential drug interactions or side effects.
    • Physicians must carefully weigh the evidence and patient profile in the absence of definitive conclusions from ongoing trials.